Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13261
Title: Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery.
Austin Authors: Liu, J J;Casley, David J;Wojta, J;Gallicchio, M;Dauer, R;Johnston, Colin I;Buxton, Brian F 
Affiliation: Department of Cardiac Surgery, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-Jan-1994
Publication information: Clinical and Experimental Pharmacology & Physiology; 21(1): 49-57
Abstract: 1. The effects of the ETA receptor antagonist BQ123 and dihydropyridine calcium antagonists on the vasoconstrictor effect of endothelin-1 (ET-1) were studied in human isolated internal mammary artery (IMA). The effect of the calcium antagonist, nisoldipine, on ET-1 levels has also been examined in cultured IMA endothelial cells (IMAEC). 2. The results showed that BQ123 and the calcium antagonists nisoldipine, isradipine, nitrendipine and nifedipine fully relaxed IMA precontracted with 3 nmol/L ET-1 with the EC50 values of 7.18 +/- 0.09 (-log mol/L) for BQ123, and 7.68 +/- 0.07, 7.02 +/- 0.12, 6.96 +/- 0.08 and 6.89 +/- 0.09 for the calcium antagonists, respectively. 3. Pretreatment of IMA with 10, 30, 100 and 300 nmol/L nisoldipine significantly depressed the maximal response (Max; 88.3 +/- 5.1, 75.2 +/- 4.9, 59.3 +/- 5.6 and 56.2 +/- 4.8% of maximal noradrenaline response versus 99.1 +/- 13.2% in control, P < 0.01) of IMA to ET-1 without a significant change in the EC50 values. 4. Pretreatment of IMA with 300 nmol/L BQ123 significantly increased both the EC50 (7.97 +/- 0.09 vs 8.36 +/- 0.08 in the control, P < 0.05) and the Max (138.1 +/- 10.2% vs the control, P < 0.01) of IMA to ET-1. 5. Incubation of IMAEC with nisoldipine for 7 h resulted in a dose-dependent (10(-8)-10(-5) mol/L) reduction up to 93.1% in ET levels in the conditioned media.(ABSTRACT TRUNCATED AT 250 WORDS)
Gov't Doc #: 8156652
URI: https://ahro.austin.org.au/austinjspui/handle/1/13261
Journal: Clinical and Experimental Pharmacology & Physiology
URL: https://pubmed.ncbi.nlm.nih.gov/8156652
Type: Journal Article
Subjects: Calcium Channel Blockers.pharmacology
Cells, Cultured
Dose-Response Relationship, Drug
Endothelin Receptor Antagonists
Endothelins.metabolism.pharmacology
Endothelium, Vascular.cytology.drug effects
Humans
In Vitro Techniques
Isradipine.pharmacology
Mammary Arteries.drug effects.metabolism
Muscle Relaxation.drug effects
Muscle, Smooth, Vascular.cytology.drug effects
Nifedipine.pharmacology
Nisoldipine.pharmacology
Nitrendipine.pharmacology
Peptides, Cyclic.pharmacology
Radioimmunoassay
Vasoconstriction.drug effects
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Mar 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.